Early childhood in America
“The Raising of America” is airing across the U.S. in an effort to spark a national discussion by exploring the history of policies that impact children’s earliest years.
Mighty Blog
The Mighty Blog features stories from around Children’s, as well as health and wellness information for raising healthy kids.
Promoting healthy development in kids during and after cancer treatment
Going through cancer treatment is difficult at any age. But because kids' bodies are rapidly growing and developing, they are more susceptible to long-term side effects that can hinder physical, cognitive and emotional development.
Give a $5, share a high five for Children’s Minnesota
Participate in the Give a $5 fundraising campaign in December donating to Children’s Minnesota and sharing a high five.
Geek Squad provides technology support for patients, families
Best Buy has run its Geek Squad precincts at Children's – Minneapolis since 2009 and Children's – St. Paul since 2013.
Lucia’s joy
Lucia has been a primary care patient at Children’s Minnesota ever since moving to Minneapolis from Guatemala at 9 months old.
Born prematurely, Sam defies odds to go home
Young Sam has been through a multitude of challenges and undergone more surgeries and procedures than most people do in their entire life.
“Children’s Pedcast”: Giving season begins at Children’s Minnesota
Annie Waters, the director of annual giving in the foundation at Children's Minnesota, talks about fundraising, philanthropy and how to donate.
Tips for a safe Halloween trick-or-treating experience
Tips and information for having a safe - and fun - Halloween with your kids.
Get to know Children’s – Minnetonka patient care manager, nurse
Erin Curtis, RN, BSN, is the patient care manager for the surgery center in Minnetonka, where teams perform more than 3,200 outpatient surgeries each year.
Sanofi US recalls all Auvi-Q epinephrine auto-injectors
Epinephrine injection manufacturer Sanofi US has voluntarily recalled all Auvi-Q (epinephrine injection, USP) products on the market, including 0.15 and 0.3 milligrams strength, because they potentially could deliver an inaccurate dosage.